Major depressive disorder and treatment-resistant mood conditions represent some of the most complex healthcare challenges of the modern era. Across international healthcare hubs—including the United Kingdom, Germany, Sweden, New Zealand, Dubai, Australia, and the Netherlands—millions of individuals seek sustainable relief from persistent emotional paralysis, severe anxiety, and cognitive exhaustion. Conventional pharmaceutical options, such as selective […]